Cell & Gene Therapy Manufacturing Services Market Set to Reach USD 74.41 Billion by 2035, Driven by Growing Demand for Advanced Therapeutic Manufacturing Solutions Globally ...

Expanding Clinical Pipelines, Contract Manufacturing Adoption, and Automation-Led Process Innovation Fuel Robust Market Growth Globally.Austin, United States, Feb. 27, 2026 (GLOBE NEWSWIRE) -- ...
GEN

Streamlining CAR/TCR T-Cell Therapy Manufacturing

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...
PV Tech

Water consumption for solar cell manufacturing could drop 79% with circular strategies

CAPEX investment for setting up the PERC production is higher in the case of a MLD setup. Image: Fraunhofer ISE A solar cell manufacturing plant can reduce water consumption by up to 79% with existing ...
GEN

Cell Surface Marker Profiling with Spectral Cytometry Optimizes CAR T Manufacturing

Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...
Informationsdienst Wissenschaft

From lab to manufacturing: Laser processes as enablers for industrial solid-state batteries

Solid-state batteries promise greater safety, higher energy density, and new degrees of freedom in cell design. Yet the path from laboratory cell to industrial production is challenging. Laser ...